ShareValue scores for NEULANDLAB.NSE: Valuation 18, Quality 54, Growth 55, Health 51.
NEULANDLAB.NSENSE
Neuland Laboratories Limited
₹21,543.00
(+7.95%)
NEULANDLAB.NSENSE
Neuland Laboratories Limited
₹21,543.00(+7.95%)
Loading chart...
Sentiment
Verdicts
Value:Overvalued
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
-6% to 9%
Rating
Trap Risk
Return
-6% to 9%
Valuation
18
Overvalued
Price vs Value
Quality
54
Moderate
Business Strength
Growth
55
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
45
Neutral
Price Trend
Company Details
About
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Market Cap$276.39B
P/E Ratio91.7
Dividend YieldNone
Sector Rank#2073
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026